Kennichi Kakudo | Molecular Diagnostics | Best Researcher Award

Published on by Biotechnology Scientist

Best Researcher Award

Kennichi Kakudo — Kindai University Nara Hospital, Japan

Kennichi Kakudo
Affiliation Kindai University Nara Hospital
Country Japan
Scopus ID 57195026520
Documents 389
Citations 12,733
h-index 59
Subject Area Molecular Diagnostics
Event Biotechnology Scientist Awards
Google Scholar uyM0bJAAAAAJ

Kennichi Kakudo is a Japanese academic pathologist and molecular diagnostics researcher recognized for his extensive contributions to thyroid pathology, endocrine tumor classification, and diagnostic standardization. His research has significantly influenced the international understanding of thyroid neoplasms and molecular pathology frameworks in endocrine oncology.[1] Through decades of scholarly activity, Kakudo has contributed to the refinement of diagnostic criteria for thyroid carcinomas and has participated in internationally recognized classification initiatives.[2]

Abstract

Kennichi Kakudo has established a distinguished academic profile in endocrine pathology and molecular diagnostics, particularly in thyroid tumor classification and diagnostic pathology. His research portfolio includes investigations into follicular variants of papillary thyroid carcinoma, molecular diagnostic testing, observer variability in thyroid lesion interpretation, and standardized classification systems for thyroid neoplasms.[3] His collaborative work has contributed to international consensus guidelines and has supported evidence-based approaches intended to reduce overtreatment in indolent thyroid tumors.[4]

Keywords

Molecular Diagnostics, Thyroid Pathology, Endocrine Oncology, Papillary Thyroid Carcinoma, Tumor Classification, Histopathology, Diagnostic Standardization, Biomarker Research, Thyroid Neoplasms, Pathological Diagnostics

Introduction

The field of thyroid pathology has undergone substantial refinement through advances in molecular diagnostics and histopathological classification systems. Researchers such as Kennichi Kakudo have contributed to the development of reproducible diagnostic criteria that improve clinical decision-making and reduce unnecessary therapeutic interventions.[2] His collaborative studies have addressed observer variation in follicular thyroid lesions and have influenced the adoption of internationally accepted classification terminology.[5]

Kakudo’s work spans diagnostic pathology, molecular biomarkers, endocrine tumor classification, and translational applications in surgical pathology. His academic contributions are widely cited within endocrine oncology and pathology literature.[1]

Research Profile

Kennichi Kakudo is affiliated with Kindai University Nara Hospital and has also been associated with Izumi City General Hospital in Japan. His Scopus author profile reports 389 indexed documents, more than 12,700 citations, and an h-index of 59, reflecting sustained academic productivity and influence within endocrine pathology research.[1]

  • Primary specialization in molecular diagnostics and endocrine pathology.
  • Extensive contributions to thyroid carcinoma classification systems.
  • Participation in collaborative international pathology consensus initiatives.
  • Research involvement in biomarker-based diagnostic methodologies.
  • Significant publication impact within pathology and oncology journals.

Research Contributions

Kakudo contributed to the landmark nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma, an initiative intended to reduce overtreatment of indolent tumors through more precise pathological classification.[3] This work represented a significant paradigm shift in endocrine oncology and diagnostic pathology.

His collaborative role in the Turin proposal established uniform diagnostic criteria for poorly differentiated thyroid carcinoma, improving diagnostic consistency across pathology laboratories and clinical settings.[2]

Additional investigations examined observer variability in follicular thyroid lesions, helping to identify limitations in diagnostic reproducibility and supporting the development of standardized interpretation approaches.[5]

  • Development of standardized thyroid tumor diagnostic criteria.
  • Research in molecular testing for thyroid nodules.
  • Studies on observer agreement in endocrine pathology.
  • Advancement of translational molecular pathology methodologies.
  • Contribution to WHO thyroid tumor classification updates.

Publications

Selected influential publications associated with Kennichi Kakudo include the following:

  1. “Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors.” JAMA Oncology, 2016.
  2. “Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach.” The American Journal of Surgical Pathology, 2007.
  3. “Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma.” The American Journal of Surgical Pathology, 2004.
  4. “Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach.” Endocrinology and Metabolism, 2022.
  5. “Impact of Molecular Testing on Surgical Decision-Making in Indeterminate Thyroid Nodules: A Global Meta-Analysis Across Test Generations.” Endocrine Pathology, 2026.

Research Impact

The academic impact of Kennichi Kakudo is reflected through high citation metrics and sustained international recognition in pathology and endocrine oncology literature.[1] His publications have been widely referenced in discussions concerning thyroid tumor nomenclature, molecular pathology, and standardized diagnostic frameworks.[4]

His work has contributed to reducing overtreatment in thyroid cancer management by promoting refined classification systems and molecularly informed pathology practices. These contributions have relevance for surgical decision-making, pathology reporting consistency, and evidence-based clinical management.[3]

Award Suitability

Kennichi Kakudo demonstrates strong suitability for recognition within the Biotechnology Scientist Awards due to his sustained contributions to molecular diagnostics, endocrine pathology, and translational oncology research.[1] His collaborative involvement in internationally influential diagnostic frameworks and WHO classification updates reflects substantial scholarly engagement and clinical relevance.[4]

  • Extensive international publication record.
  • High citation impact in pathology and oncology.
  • Contributions to global diagnostic standardization.
  • Influence on molecular diagnostic methodologies.
  • Long-standing academic and clinical research engagement.

Conclusion

Kennichi Kakudo has contributed significantly to the advancement of thyroid pathology and molecular diagnostics through internationally recognized research and collaborative classification initiatives. His scholarly work has influenced diagnostic reproducibility, tumor classification systems, and evidence-based endocrine oncology practices.[2] The breadth of his research activity and citation impact supports his recognition within the context of scientific and biotechnology-related academic awards.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Kennichi Kakudo, Author ID 57195026520. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57195026520
  2. Volante M, Collini P, Nikiforov YE, Sakamoto A, Kakudo K, et al. (2007). Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. The American Journal of Surgical Pathology.
  3. Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, et al. (2016). Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncology.
    https://doi.org/10.1001/jamaoncol.2016.0386
  4. Jung CK, Bychkov A, Kakudo K. (2022). Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach. Endocrinology and Metabolism.
  5. Kennichi Kakudo 1, Yanhua Bai, Zhiyan Liu, Takashi Ozaki 2012 Encapsulated papillary thyroid carcinoma, follicular variant: a misnomer.
    https://pubmed.ncbi.nlm.nih.gov/

Zerrin Kutlu | Molecular | Excellence in Research Award

Published on by Biotechnology Scientist

Assoc. Prof. Dr. Zerrin Kutlu | Molecular | Excellence in Research Award

Researcher at Ataturk University | Turkey

Assoc. Prof. Dr. Zerrin Kutlu is a distinguished biochemist whose research excellence is demonstrated through her impactful contributions to oxidative stress biology, endoplasmic reticulum stress, inflammation, metabolic disorders, and therapeutic drug discovery. With 211 citations across 198 documents, 15 publications, and a Scopus h-index of 9, she has established a credible scientific footprint in translational biochemistry and experimental pharmacology. Her research spans ischemic heart injury, diabetes-related complications, sepsis-induced organ damage, ferroptosis, and antioxidant-based cytoprotective strategies. She has extensively studied avasopasem manganese (a SOD mimetic), ER-stress modulators, nanoformulations for wound healing, and bioactive natural compounds with therapeutic potential. Her experimental work includes the elucidation of molecular pathways such as unfolded protein response mechanisms, inflammatory cascades, prostaglandin receptor signaling, and oxidative injury biomarkers. She has authored SCI/SCI-Expanded articles and contributed multiple book chapters reflecting her sustained scientific productivity. Her involvement in dermocosmetic innovation and boron-based bioactive molecule development illustrates strong translational impact. Her research outputs demonstrate originality, advanced methodology, and significant biomedical relevance, solidifying her suitability for the Excellence in Research Award.

Profiles : Scopus | ORCID | Google Scholar

Featured Publications

Dumlu, F. A., Aydin, T., Odabasoglu, F., Berktas, O. A., Kutlu, Z., Erol, H. S., … (2019). Anti-inflammatory and antioxidant properties of jervine, a steroidal alkaloid from rhizomes of Veratrum album. Phytomedicine, 55, 191–199. (Cited by: 46)

Koc, K., Geyikoglu, F., Cakmak, O., Koca, A., Kutlu, Z., Aysin, F., Yilmaz, A., … (2021). The targets of β-sitosterol as a novel therapeutic against cardio-renal complications in acute renal ischemia/reperfusion damage. Naunyn-Schmiedeberg’s Archives of Pharmacology, 394(3), 469–479. (Cited by: 44)

Karaoğlan, E. S., Albayrak, A., Kutlu, Z., & Bayır, Y. (2018). Gastroprotective and antioxidant effects of Eremurus spectabilis Bieb. methanol extract and its isolated component isoorientin on indomethacin-induced gastric ulcer. Acta Cirurgica Brasileira, 33, 609–618. (Cited by: 30)

Akpinar, E., Kutlu, Z., Kose, D., Aydin, P., Tavaci, T., Bayraktutan, Z., Yuksel, T. N., … (2022). Protective effects of idebenone against sepsis-induced acute lung damage. Journal of Investigative Surgery, 35(3), 560–568. (Cited by: 25)

Kutlu, Z., Celik, M., Bilen, A., Halıcı, Z., Yıldırım, S., Karabulut, S., Karakaya, S., … (2020). Effects of umbelliferone isolated from the Ferulago pauciradiata Boiss. & Heldr. plant on cecal ligation and puncture-induced sepsis model in rats. Biomedicine & Pharmacotherapy, 127, 110206. (Cited by: 21)

Ning Zhang | Molecular biotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Assoc. Prof. Dr. Ning Zhang | Molecular Biotechnology | Best Researcher Award

Associate Professor at Liaocheng university | China

Assoc. Prof. Dr. Ning Zhang, a distinguished neuroscientist of Mongolian ethnicity, is a member of the Communist Party and currently focuses her research on neuroinflammatory immunity and myelin regeneration. She earned her doctoral degree in Neuroscience from Tierärztliche Hochschule Hannover, Germany, in November 2015. Dr. Zhang’s research primarily investigates the regulatory mechanisms of neuroinflammation and immune responses in neurodegenerative diseases, emphasizing the processes of remyelination and neuronal repair. Her studies further explore the intricate interactions among glial cells in the central nervous system during both development and disease progression. She is also deeply engaged in identifying novel therapeutic targets for neurodegenerative conditions and developing bioactive interventions aimed at mitigating neuronal damage. Dr. Zhang has made substantial contributions to the field through her publications and scientific discoveries, advancing understanding of cellular and molecular mechanisms underlying neural repair. Her work bridges fundamental neuroscience with translational approaches to improve clinical outcomes in neurodegenerative disorders. According to her Scopus profile, Dr. Zhang has authored 62 scientific documents, which have collectively garnered 868 citations across 667 publications, reflecting a significant impact in the global neuroscience community. She maintains an h-index of 19, demonstrating both the depth and influence of her research contributions in neuroinflammatory and regenerative neuroscience.

Profile: Scopus

Featured Publications

Zhang, N., et al. (2025). Ketogenic diet attenuates microglia-mediated neuroinflammation by inhibiting NLRP3 inflammasome activation via HDAC3 inhibition to activate mitophagy in experimental autoimmune encephalomyelitis. Food & Function. 3 citations

Zhang, N., et al. (2025). Exogenous ketogenic supplements can mitigate the susceptibility to Alzheimer’s disease induced by chronic sleep deprivation: Emerging role of Sirt1 in ferroptosis. Food Science and Human Wellness. 0 citations

Zhang, N., et al. (2025). Cetirizine platinum(IV) complexes with antihistamine properties inhibit tumor metastasis by suppressing angiogenesis and boosting immunity. Journal of Inorganic Biochemistry. 3 citations

Zhang, N., et al. (2024). Dynamic effects of ketogenic diet on autophagy and cell cycle in a mouse model of CT26+ colon cancer. Pakistan Journal of Zoology. 0 citations

Zhang, N., et al. (2024). Phase separation investigation of Axitinib in supersaturated solution. Crystals. 0 citations

Yu Fang | Molecular biotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Prof. Dr. Yu Fang | Molecular biotechnology | Best Researcher Award

Full Professor at Fujian Institute of Research on the Structure of Matter | China

Dr. Yu Fang is a distinguished chemist whose research lies at the interface of materials chemistry and supramolecular science, particularly in the design and synthesis of Porous Coordination Cages (PCCs) and Metal–Organic Frameworks (MOFs). His work focuses on developing advanced porous materials for applications in catalysis, gas storage, molecular recognition, and energy conversion. Dr. Fang has made significant contributions to understanding host–guest chemistry, self-assembly mechanisms, and structure–property relationships in coordination materials. His innovative research has been widely recognized in leading journals such as Nature Communications, Angewandte Chemie International Edition, Journal of the American Chemical Society, and Chemical Society Reviews. Through collaborative projects and pioneering insights, Dr. Fang’s studies have bridged molecular design and functional materials engineering, influencing both academic and industrial research in advanced materials. He has published extensively, contributing to the development of next-generation coordination architectures with tailored porosity and dynamic behavior for chemical and environmental applications. With 7132 citations and an h-index of 26 according to his Scopus profile, Dr. Fang’s scientific impact reflects both productivity and quality, positioning him as a leading figure in coordination chemistry and materials innovation.

Profile: Google Scholar | Orcid

Featured Publications

Liang, Y., Yang, X., Wang, X., Guan, Z.-J., Xing, H., & Fang, Y. (2023). Nature Communications, 14, 5223.

Su, Z., Liu, K.-K., Xu, Y.-Q., Yan, B., Wang, S., Guan, Z.-J., Zou, Y., & Fang, Y. (2024). Angewandte Chemie International Edition, 64(9), e202420945.

Peng, Y., Yuan, L., Liu, K.-K., Jin, S., & Fang, Y. (2024). Angewandte Chemie International Edition, 64(12), e202423055.

Liang, Y., Xie, G., Liu, K.-K., Jin, M., Chen, Y., Yang, X., Guan, Z.-J., Xing, H., & Fang, Y. (2024). Angewandte Chemie International Edition, 64(1), e202416884.

He, H.-H., Yuan, J.-P., Cai, P.-Y., Wang, K.-Y., Feng, L., Kirchon, A., Li, J., Zhang, L.-L., Zhou, H.-C., & Fang, Y. (2023). Journal of the American Chemical Society, 145, 17164–17175.

Fang, Y., Powell, J., Li, E., Wang, Q., Perry, Z., Kirchon, A., Yang, X., Xiao, Z., Zhu, C., Zhang, L., Huang, F., & Zhou, H.-C. (2019). Chemical Society Reviews, 48(17), 4707–4730.

Liang, Y., Li, E., Wang, K., Guan, Z.-J., He, H.-H., Zhang, L.-L., Zhou, H.-C., Huang, F., & Fang, Y. (2022). Chemical Society Reviews, 51, 8378–8405.